[1] 郭宁子,辛中帅,杨化新.微球制剂质量控制研究进展[J].中国新药杂志,2015,24(18):2115 GUO NZ,XIN ZS,YANG HX.Research progress in quality control of microspheres[J].Chin J New Drugs,2015,24(18):2115
[2] 徐明新,陶颖,陈园园.长效缓释微球制剂生产技术的发展现状[J].现代生物医学进展,2017,17(19):3772 XU MX,TAO Y,CHEN YY.Advanced Studies in the preparation techniques of sustained-release microsphere[J].Progr Mod Biomed,2017,17(19):3772
[3] 梅兴国,黄似焕,白承之.注射用缓释微球的国内外发展现状[J].药物研究,2014,31(1):27 MEI XG,HUANG SH,BAI CZ.Worldwide development status of injectable microspheres for sustained release[J].Pharm Res,2014,31(1):27
[4] 梁苑英竹,林晓鸣,刘万卉,等.肽类微球注射剂释放度实验评价研究进展[J].中国新药杂志,2017,26(24):2918 LIANG YYZ,LIN XM,LIU WH,et al.Evaluation methods of in vitro release rate of peptide microsphere injections:a review[J].Chin J New Drugs,2017,26(24):2918
[5] HU L,ZHANG H,SONG W.An overview of preparation and evaluation sustained-release injectable microspheres[J].Microencapsul,2013,30(4):369
[6] MULLARD A.2012 FDA drug approvals[J].Nat Rev Drug Discov,2013,12(2):87
[7] 李想,孙考祥,李又欣.长效微球制剂产业化研究进展[J].中国药学杂志,2019,54(21):1729 LI X,SUN KX,LI YX.Progress in the Industrialization of Sustained-release Microsphere[J]Chin Pharm J,2019,54(21):1729
[8] WAN F,YANG MS.Design of PLGA-based depot delivery systemsfor biopharmaceuticals prepared by spray drying[J].Int JPharm,2016,498(1-2):82
[9] QI F,WU J,YANG TY,et al.Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification[J].Acta Biomater,2014,10(10):4247
[10] JAIN RA.The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices[J].Biomaterials,2000,21(23):2475
[11] 郭宁子,辛中帅,孙悦.激光散射法测定注射用醋酸亮丙瑞林微球粒径及其分布[J].中国新药杂志,2017,26(8):886 GUO NZ,XIN ZS,SUN Y,Determination of size and size distribution of leuprorelin acetatemicrospheres for injection using laser diffraction method[J].Chin J New Drugs,2017,26(8):886
[12] 彭芳,周凤梅,刘万卉.注射用缓释微球的体外释放度研究状[J].齐鲁药事,2011,30(5):285 PENG F,ZHOU FM,LIU WH.Study on in vitro release of sustained-release microspheres for injection[J].Qilu Pharm Aff,2011,30(5):285
[13] GITE S,CHOGALE M,PATRAVALE V.Development and validation of a discriminating dissolution method for atorvastatin delayed-release nanoparticles using a flow through cell:a comparative study using USP apparatus 4 and 1[J].Dissol Technol,2016,23(2):14
[14] 李辉,赵悦清,蒋妮谚,等.基于流通池装置的新溶出方法用于尼莫地平片的一致性评价[J].中国药科大学学报,2018,49(3):301 LI H,ZHAO YQ,JIANG NY.A new method based on flow-through cell apparatus to evaluate dissolution consistency of nimodipine tablets[J].J China Pharm Univ,2018,49(3):301
[15] OKADA H.One-and three-month release injectable microspheres of the LH-RH superagonistleuprorelin acetate[J].Adv Drug Del Rev,1997,28(1):43
[16] ANDERSON JM,SHIVER MS.Biodegradation and biocompatibilityof PLA and PLGA microsphere[J].Adv Drug Deliv Rev,1997, 28(1):5
[17] LUCKE A,KIERMAIER J,GPFERICH A.Peptide acylationbypoly(alpha-hydroxy esters)[J].Pharm Res,2002,19(2):175
[18] 张瑞卿,夏云,刘婧,等.醋酸亮丙瑞林原位注射制剂的制备及其体内外释放性能的研究[J].中国医院药学杂志,2019,39(7):691 ZHANG RQ,XIA Y,LIU J,et al.Preparation of leuprolide acetate in situ injection and its in vitro and in vivo release properties[J].Chin Hosp Pharm,2019,39(7):691